DOACs Overview
Apixaban, rivaroxaban, edoxaban, and dabigatran offer predictable pharmacokinetics and fewer drug interactions compared to warfarin. They do not require routine INR monitoring.
Direct oral anticoagulants have largely replaced warfarin for stroke prevention in non-valvular AF. This review compares efficacy, safety, and practical prescribing considerations.
By Prof. James van Zyl 7 min read 1 CPD
Apixaban, rivaroxaban, edoxaban, and dabigatran offer predictable pharmacokinetics and fewer drug interactions compared to warfarin. They do not require routine INR monitoring.